Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 6, 2013, Pages 1454-1462

  Han, Wei Qing ^a,b   Zhu, Qing ^a   Hu, Junping ^a   Li, Pin Lan ^a   Zhang, Fan ^a   Li, Ningjun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Prolyl hydroxylase domain containing protein; Renal fibrosis; Smad signaling pathway

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; P CADHERIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE DOMAIN CONTAINING PROTEIN 1; PROLYL HYDROXYLASE DOMAIN CONTAINING PROTEIN 2; PROLYL HYDROXYLASE DOMAIN CONTAINING PROTEIN 3; PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANIMALS; ANOXIA; BLOTTING, WESTERN; CELLS, CULTURED; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY TUBULES; PROCOLLAGEN-PROLINE DIOXYGENASE; RATS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84875790987     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.02.029     Document Type: Article

References (65)

1. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat. Rev. Nephrol. 2011, 7:684-696.
2. Hills C.E., Squires P.E. The role of TGF-beta and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 2011, 22:131-139.
3. Hills C.E., Squires P.E. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am. J. Nephrol. 2010, 31:68-74.
4. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 2002, 110:341-350.
5. Kanwar Y.S., Wada J., Sun L., Xie P., Wallner E.I., Chen S., Chugh S., Danesh F.R. Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. (Maywood) 2008, 233:4-11.
6. Sharma K., Ziyadeh F.N. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995, 44:1139-1146.
7. Carew R.M., Wang B., Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res. 2012, 347:103-116.
8. Burns W.C., Twigg S.M., Forbes J.M., Pete J., Tikellis C., Thallas-Bonke V., Thomas M.C., Cooper M.E., Kantharidis P. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J. Am. Soc. Nephrol. 2006, 17:2484-2494.
9. Yeh Y.C., Wei W.C., Wang Y.K., Lin S.C., Sung J.M., Tang M.J. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am. J. Pathol. 2010, 177:1743-1754.
10. Schnaper H.W., Hayashida T., Hubchak S.C., Poncelet A.C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Renal. Physiol. 2003, 284:F243-F252.
11. Nangaku M., Fujita T. Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertens. Res. 2008, 31:175-184.
12. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 2006, 17:17-25.
13. Higgins D.F., Kimura K., Bernhardt W.M., Shrimanker N., Akai Y., Hohenstein B., Saito Y., Johnson R.S., Kretzler M., Cohen C.D., Eckardt K.U., Iwano M., Haase V.H. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 2007, 117:3810-3820.
14. Copple B.L. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms. Liver Int. 2010, 30:669-682.
15. Moon J.O., Welch T.P., Gonzalez F.J., Copple B.L. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G582-G592.
16. Zhou G., Dada L.A., Wu M., Kelly A., Trejo H., Zhou Q., Varga J., Sznajder J.I. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 297:L1120-L1130.
17. 2-induced cell death in colon cancer cells via the Smad2/ERK1/2/HIF-1alpha pathway. Int. J. Mol. Med. 2012, 29:906-912.
18. Basu R.K., Hubchak S., Hayashida T., Runyan C.E., Schumacker P.T., Schnaper H.W. Interdependence of HIF-1alpha and TGF-beta/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am. J. Physiol. Renal. Physiol. 2011, 300:F898-F905.
19. Ueno M., Maeno T., Nomura M., Aoyagi-Ikeda K., Matsui H., Hara K., Tanaka T., Iso T., Suga T., Kurabayashi M. Hypoxia-inducible factor-1alpha mediates TGF-beta-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2011, 300:L740-L752.
20. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
21. 2 sensing. Science 2001, 292:464-468.
22. 2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
23. McMahon S., Charbonneau M., Grandmont S., Richard D.E., Dubois C.M. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J. Biol. Chem. 2006, 281:24171-24181.
24. Tug S., Delos Reyes B., Fandrey J., Berchner-Pfannschmidt U. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors. Biochem. Biophys. Res. Commun. 2009, 384:519-523.
25. Takeda K., Cowan A., Fong G.-H. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 2007, 116:774-781.
26. Rosenberger C., Rosen S., Shina A., Frei U., Eckardt K.U., Flippin L.A., Arend M., Klaus S.J., Heyman S.N. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney. Nephrol. Dial. Transplant. 2008, 23:3472-3478.
27. Takeda K., Aguila H.L., Parikh N.S., Li X., Lamothe K., Duan L.J., Takeda H., Lee F.S., Fong G.H. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 2008, 111:3229-3235.
28. Li N., Yi F., Sundy C.M., Chen L., Hilliker M.L., Donley D.K., Muldoon D.B., Li P.L. Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys. Am. J. Physiol. Renal Physiol. 2007, 292:F207-F216.
29. Hills C.E., Al-Rasheed N., Al-Rasheed N., Willars G.B., Brunskill N.J. C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 2009, 296:F614-F621.
30. Wang Z., Tang L., Zhu Q., Yi F., Zhang F., Li P.L., Li N. Hypoxia-inducible factor-1alpha contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int. 2011, 79:300-310.
31. Huang J., Zhao Q., Mooney S.M., Lee F.S. Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J. Biol. Chem. 2002, 277:39792-39800.
32. Percy M.J., Zhao Q., Flores A., Harrison C., Lappin T.R., Maxwell P.H., McMullin M.F., Lee F.S. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:654-659.
33. Zhu Q., Liu M., Han W., Li P.L., Wang Z., Li N. Overexpression of HIF prolyl-hydoxylase-2 transgene in the renal medulla induced a salt-sensitive hypertension. J. Cell Mol. Med. 2012.
34. Zhu Q., Wang Z., Xia M., Li P.L., Van Tassell B.W., Abbate A., Dhaduk R., Li N. Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension 2011, 58:657-664.
35. Wang Z., Zhu Q., Xia M., Li P.L., Hinton S.J., Li N. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla. Hypertension 2010, 55:1129-1136.
36. Tacchini L., Gammella E., De Ponti C., Recalcati S., Cairo G. Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J. Biol. Chem. 2008, 283:20674-20686.
37. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7:415-428.
38. Masszi A., Di Ciano C., Sirokmany G., Arthur W.T., Rotstein O.D., Wang J., McCulloch C.A., Rosivall L., Mucsi I., Kapus A. Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am. J. Physiol. Renal. Physiol. 2003, 284:F911-F924.
39. Robert G., Gaggioli C., Bailet O., Chavey C., Abbe P., Aberdam E., Sabatie E., Cano A., Garcia de Herreros A., Ballotti R., Tartare-Deckert S. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res. 2006, 66:7516-7523.
40. Li C.X., Xia M., Han W.Q., Li X.X., Zhang C., Boini K.M., Liu X.C., Li P.L. Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes. Cell. Physiol. Biochem. 2011, 27:691-702.
41. Larue L., Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005, 24:7443-7454.
42. Tamiya S., Liu L., Kaplan H.J. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest. Ophthalmol. Vis. Sci. 2010, 51:2755-2763.
43. Zhou Q., Zeng R., Xu C., Liu L., Chen L., Kou P., Pei G., Bai S., Zhang Y., Li C., Rong S., Han M., Xu G. Erbin inhibits TGF-beta1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway. J. Mol. Med. (Berl) 2012, 90:563-574.
44. Kopp J.B. TGF-beta signaling and the renal tubular epithelial cell: too much, too little, and just right. J. Am. Soc. Nephrol. 2010, 21:1241-1243.
45. Shih S.C., Claffey K.P. Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors 2001, 19:19-34.
46. Chae K.S., Kang M.J., Lee J.H., Ryu B.K., Lee M.G., Her N.G., Ha T.K., Han J., Kim Y.K., Chi S.G. Opposite functions of HIF-alpha isoforms in VEGF induction by TGF-beta1 under non-hypoxic conditions. Oncogene 2011, 30:1213-1228.
47. Takeda K., Cowan A., Fong G.H. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 2007, 116:774-781.
48. Schodel J., Klanke B., Weidemann A., Buchholz B., Bernhardt W., Bertog M., Amann K., Korbmacher C., Wiesener M., Warnecke C., Kurtz A., Eckardt K.U., Willam C. HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. Am. J. Pathol. 2009, 174:1663-1674.
49. Aprelikova O., Chandramouli G.V., Wood M., Vasselli J.R., Riss J., Maranchie J.K., Linehan W.M., Barrett J.C. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J. Cell. Biochem. 2004, 92:491-501.
50. Marxsen J.H., Stengel P., Doege K., Heikkinen P., Jokilehto T., Wagner T., Jelkmann W., Jaakkola P., Metzen E. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem. J. 2004, 381:761-767.
51. Janssen H.L., Haustermans K.M., Sprong D., Blommestijn G., Hofland I., Hoebers F.J., Blijweert E., Raleigh J.A., Semenza G.L., Varia M.A., Balm A.J., van Velthuysen M.L., Delaere P., Sciot R., Begg A.C. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int. J. Radiat. Oncol. Biol. Phys. 2002, 54:1537-1549.
52. Su Y., Loos M., Giese N., Metzen E., Buchler M.W., Friess H., Kornberg A., Buchler P. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer. Cancer 2012, 118:960-972.
53. Mackinnon A.C., Gibbons M.A., Farnworth S.L., Leffler H., Nilsson U.J., Delaine T., Simpson A.J., Forbes S.J., Hirani N., Gauldie J., Sethi T. Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3. Am. J. Respir. Crit. Care Med. 2012, 185:537-546.
54. Zeisberg M., Duffield J.S. Resolved: EMT produces fibroblasts in the kidney. J. Am. Soc. Nephrol. 2010, 21:1247-1253.
55. Strutz F., Okada H., Lo C.W., Danoff T., Carone R.L., Tomaszewski J.E., Neilson E.G. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 1995, 130:393-405.
56. Camara J., Jarai G. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis Tissue Repair 2010, 3:2.
57. Valcourt U., Kowanetz M., Niimi H., Heldin C.H., Moustakas A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 2005, 16:1987-2002.
58. Kawakita T., Espana E.M., Higa K., Kato N., Li W., Tseng S.C. Activation of Smad-mediated TGF-beta signaling triggers epithelial-mesenchymal transitions in murine cloned corneal progenitor cells. J. Cell. Physiol. 2012, 228:225-234.
59. Brandl M., Seidler B., Haller F., Adamski J., Schmid R.M., Saur D., Schneider G. IKK(alpha) controls canonical TGF(ss)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. J. Cell Sci. 2010, 123:4231-4239.
60. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 2003, 112:1486-1494.
61. Xu J., Lamouille S., Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009, 19:156-172.
62. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
63. Kriz W., Kaissling B., Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?. J. Clin. Invest. 2011, 121:468-474.
64. Fragiadaki M., Mason R.M. Epithelial-mesenchymal transition in renal fibrosis - evidence for and against. Int. J. Exp. Pathol. 2011, 92:143-150.
65. Zeisberg M., Neilson E.G. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 2010, 21:1819-1834.